Abstract:The selective inhibition of expression of specific genes by oligonucleotides via an antisense or antigene strategy provides an attractive and elegant approach to drug discovery. Several requirements must be fulfilled by a potential antisense oligonucleotide including the improvements in their stability to nuclease digestion, in their ability to penetrate the cell membrane and in their efficient hybridization to the target RNA/DNA. Isonucleosides represent a novel class of carbohydrate modified nucleosides in which the nucleobase is linked to various positions of ribose other than C1'. The torsion angles in the sugar phosphate backbones of such oligonucleotides consisting of isonucleosides exhibit profound changes compared to regular oligonucleotides. These alternations in torsion angles might affect the recognition of such oligomers by nuclease. It could also be anticipated that the bases in the modified oligonucleotides retain their hybridization properties with complementary sequences. In the first part of this paper, we discussed the hybridization properties and enzymatic stability of oligonucleotides bearing such isonucleosides. It is reported that several types of peptides, such as nuclear transport signal sequence, viral fusion peptides, hydrophobic peptides, and signal peptides, have shown intrinsic ability to perturb cell membrane. It would be interesting to investigate whether such kinds of peptide conjugate could be used for the purpose of improving their cell membrane permeability. In the second and third part of this paper, we reported the synthesis and biological properties of antisense oligonucleotide conjugates. Finally, we described the formation of parallel intermolecular G quadruplex structure by isonucleoside.

Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 Cells.

Construction and Identification of an Antisense Glucose Transporter-1 Plasmid

Inhibition of Cell Proliferation and Glucose Uptake in Human Laryngeal Carcinoma Cells by Antisense Oligonucleotides Against Glucose Transporter‐1

A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide.

A Novel Peptide-Equipped Exosomes Platform for Delivery of Antisense Oligonucleotides

Effect Of Antisense Oligodeoxynucleotides Glucose Transporter-1 On Enhancement Of Radiosensitivity Of Laryngeal Carcinoma

Advance in Synthesis and Application of Peptide-Oligonucleotide Conjugates

Studies on drug targeting to nucleic acids

Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.

Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma

Effects of Suppressing Glucose Transporter-1 by an Antisense Oligodeoxynucleotide on the Growth of Human Hepatocellular Carcinoma Cells

Structural Optimization and Additional Targets Identification of Antisense Oligonucleotide G3139 Encapsulated in a Neutral Cytidinyl-Lipid Combined with a Cationic Lipid in Vitro and in Vivo

Synthesis, Biophysical Properties, and Antitumor Activity of Antisense Oligonucleotides Conjugated with Anisamide

Inhibition of GLUT-1 Expression and the PI3K/Akt Pathway to Enhance the Chemosensitivity of Laryngeal Carcinoma Cells in Vitro

Modified ASO Conjugates Encapsulated with Cytidinyl/cationic Lipids Exhibit More Potent and Longer-Lasting Anti-Hcc Effects

High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of Sirna.

Intracellular Condensates of Oligopeptide for Targeting Lysosome and Addressing Multiple Drug Resistance of Cancer

Targeted modulation of gene expression through receptor‐specific delivery of small interfering RNA peptide conjugates

Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil

Enhanced Therapeutic siRNA to Tumor Cells by a pH-Sensitive Agmatine-Chitosan Bioconjugate.

The Chemistry and Biology of Oligonucleotide Conjugates